Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Harry, de Wit"'
Autor:
Johanne, Rozema, Ivar, van Asten, Beau, Kwant, Robby E, Kibbelaar, Nic J G M, Veeger, Harry, de Wit, Eric N, van Roon, Mels, Hoogendoorn
Publikováno v:
European Journal of Haematology, 109(6), 772-778. Wiley
OBJECTIVES: In patients with myelodysplastic syndromes (MDS) with >20 transfusions and ferritin levels >1000 μg/L, international guidelines recommend iron chelation therapy (ICT). The study's objective was to determine guideline adherence and the in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2175c6bd54def0087478050c5b5c7652
https://doi.org/10.1111/ejh.13865
https://doi.org/10.1111/ejh.13865
Autor:
Harry de Wit, Johanne Rozema, Mels Hoogendoorn, Christiaan L Slim, Robby E. Kibbelaar, Nic J. G. M. Veeger, Eric N. van Roon
Publikováno v:
Transfusion, 61(10), 2877-2884. Wiley
BACKGROUND: Ineffective hematopoiesis in patients with myelodysplastic syndromes (MDS) often results in transfusion dependence. The burden of frequent transfusions in the real-world MDS population is largely unknown.STUDY DESIGN AND METHODS: An obser
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec167d0625048c6d33b8da8bd1724076
https://doi.org/10.1111/trf.16631
https://doi.org/10.1111/trf.16631
Publikováno v:
Haematologica, Vol 99, Iss 2 (2014)
Externí odkaz:
https://doaj.org/article/a628231d74034bf884ed25239b5b193c
Autor:
Ivar Van Asten, Eric N. van Roon, Beau Kwant, Mels Hoogendoorn, Nic J. G. M. Veeger, Harry de Wit, Robby E. Kibbelaar, Johanne Rozema
Publikováno v:
Blood. 138:1986-1986
Background: The majority of patients with myelodysplastic syndromes (MDS) needs regular blood transfusions and becomes transfusion dependent. Blood transfusions temporarily alleviate anemia-related symptoms, but can be accompanied by adverse events,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::06925e6351d106f161a30f60da2b152a
https://doi.org/10.1182/blood-2021-152096
https://doi.org/10.1182/blood-2021-152096
Autor:
Jurgen A. Kooren, Henk J Adriaansen, Harry de Wit, Elianne A. Roelandse-Koop, Joost H. N. Schuitemaker, Johannes J M L Hoffmann, Karin C.A.M. Nabbe
Publikováno v:
de Wit, H, Nabbe, KCAM, Kooren, J A, Adriaansen, H J, Koop, E A, Schuitemaker, J H N & Hoffmann, J J M L 2011, ' Reference Values of Fetal Erythrocytes in Maternal Blood During Pregnancy Established Using Flow Cytometry ', American Journal of Clinical Pathology, vol. 136, no. 4, pp. 631-636 . https://doi.org/10.1309/AJCPHL3VXY0VMLXL
American Journal of Clinical Pathology, 136(4), 631-636. American Society of Clinical Pathologists
American Journal of Clinical Pathology, 136(4), 631-636. American Society of Clinical Pathologists
The aim of our study was to assess the fetal RBC count in maternal blood during uncomplicated pregnancies from 26 weeks onward. We used a flow cytometric method specifically designed for use in a routine hematology analyzer. Pregnant women were recru
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e650e89e4e588bacdd7a8d7fcb279d36
https://research.vumc.nl/en/publications/80617000-f986-4710-86db-a2c24175aecf
https://research.vumc.nl/en/publications/80617000-f986-4710-86db-a2c24175aecf
Publikováno v:
Haematologica. 99:e26-e27
The introduction of the novel oral anticoagulants (NOAC), such as the direct Factor Xa-inhibitors rivaroxaban and apixaban and the thrombin-inhibitor dabigatran, have provided an effective and safe alternative to vitamin K antagonists (VKA) for the p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::887479afaf7f6e4cd0bb9ab4ee90c1c2
https://doi.org/10.3324/haematol.2013.097287
https://doi.org/10.3324/haematol.2013.097287